Responses
Plenary 03: Oral Abstract Presentations – Ovarian Cancer
AS11. Ovarian cancer
PO008/#393 Timed adoptive T-cell therapy during chemotherapy in platinum sensitive recurrent epithelial ovarian cancer, the ovacure phase I/II trial
Compose a Response to This Article
Other responses
No responses have been published for this article.